The UroLift^® System Leadership Team

Sarah Cooley has served as our Human Resources Director since April of 2019. She has worked in the Medical Device industry for the past eight years, holding various leadership positions in Human Resources at Natus Medical and CooperVision. She has a diverse background in HR, holding specialized roles in Compensation, Benefits, Corporate Wellness and Learning & Development. Her role is a partner to the Teleflex Interventional Urology Leadership Team and oversees employee development, talent acquisition and culture enhancement strategies.  

Jen Dallaire is the Vice President, Finance, Teleflex Interventional Urology. She has more than 20 years of financial experience with Teleflex. Jen has held numerous roles of substantial responsibility throughout her career with Teleflex, including Vice President of Finance for the Surgical Business Unit and, most recently, Vice President of Finance for the Interventional Business Unit. Jen was named Vice President of Finance for Interventional upon completing the VSI acquisition. Jen holds a B.S. in Accounting from the University of Massachusetts Dartmouth.

Trey Dorman is the Vice President, U.S. Sales, Teleflex Interventional Urology. Trey joined NeoTract | Teleflex in 2014 as one of the first members of the sales team holding leadership positions as Regional Business Manager and Area Sales Director. With more than 14 years of urology medical device sales experience, Trey’s extensive knowledge of reimbursement, U.S. health care partners, and several years of experience leading territories across Interventional Urology’s sales footprint, helps strengthen UroLift’s sales strategy. Prior to joining Interventional Urology, Trey held sales positions with Bard and Medtronic. He holds a B.A. in Management & Marketing from the Lindenwood University in St. Louis, Mo.

Susan Hopkins is the Vice President, Commercial Marketing. Susan leads brand strategy, campaign development, advertising and promotions, competitive intelligence, market research, and marketing communications for Teleflex Interventional Urology. Susan has served in leadership roles at Procter & Gamble, Johnson & Johnson, Genentech, and other medical technology companies. Susan is focused on customer loyalty and gathers the voice of customer input to develop meaningful, patient-focused strategies and actions. Her most recent corporate role before joining Teleflex in 2018 was Chief Marketing Officer at Accuray, a radiation therapy company. Susan’s commitment to helping people, whether making critical decisions about their medical care or developing their professional capabilities, is a common thread throughout her career. She holds a B.F.A in writing from New York University and an M.B.A from the University of Rochester’s Simon School of Business.

Stan Hsu, Sr. Director, Program Management & Strategic Planning joined NeoTract | Teleflex in August 2017 and has built and established the Program Management Office (PMO) function. Prior to joining NeoTract | Teleflex, Stan spent 15 years at Stryker in various business units in roles of increasing responsibility within Manufacturing Engineering, Operations, Quality and Regulatory, Supply Chain Operations, and PMO. Stan holds a B.S. in Industrial Engineering from Stanford University and an M.B.A. from Cox School of Business at Southern Methodist University.

Jennifer Kiyoi joined NeoTract | Teleflex in August 2014 as Manager, Manufacturing Engineering and has held various roles of increasing responsibility prior to her current position of Vice President of Operations as of August 2021. Prior to joining our company, Jennifer held various positions within Operations and R&D for MAQUET, Boston Scientific and Guidant. Jennifer graduated with a B.S. in Biomedical Engineering from Northwestern University.

Val Vietengruber is the Vice President, Reimbursement and Health Policy for Teleflex Interventional Urology. She brings more than 30 years of healthcare policy, reimbursement, and government affairs experience to Teleflex. Most recently, Val was responsible for the healthcare policy, coverage, and payment strategy at Freenome Holdings, Inc. Prior to Freenome, Val worked for NanoString Technologies and FUJIFILM SonoSite. Val also led a successful consulting firm that provided medical coding, lobbying efforts, and reimbursement services to individual practices, nonprofits, and global healthcare firms. Val holds a B.A. in Political Science and Government from the University of Washington.

Jacqueline Welch serves as Vice President of Teleflex’s Global Clinical Operations and Scientific Services and has been with the company since November 2004. She also serves as Medical Director for Teleflex Interventional Urology. Prior to joining Teleflex, Dr. Welch pursued research and innovation through a variety of technology and clinical roles at Stanford University, Exploramed, Guidant, Pfizer, NASA Ames Research Center, Lawrence Livermore National Laboratory and Lawrence Berkeley National Laboratory. Dr. Welch is an affiliate member of the American Urological Association and serves as the industry representative of the Gastroenterology and Urology Devices Panel of the Food and Drug Administration. Dr. Welch holds an M.D. from Stanford University and B.S., M.S., and Ph.D. in Mechanical Engineering from Stanford University.  

Brian Wilkins joined Teleflex Interventional Urology as Vice President, Research and Development in August 2022. He brings more than 25 years of experience in the medical device industry, designing, developing, and commercializing medical devices to solve unmet needs primarily focused on vascular disease. Over the past two decades, Brian held multiple R&D roles at Cordis Corporation, most recently serving as Director of Research and Development. In addition, Brian has extensive experience working with global OEMs and evaluating new medical device technologies. Brian holds an M.B.A from University of California, Berkeley Haas School of Business and an M.S. in Biomedical Engineering from Tulane University.